** Shares in Fagron FAGRO.BR rise 6% after the Belgian
healthcare company posted a 16% jump in Q1 revenue to 181 mln
euros ($199 mln) driven by organic growth, acquisitions and
currency exchange effects
** The group continues to see a mid-to-high single digit
organic revenue growth for 2023 and maintains medium-term
objectives
** "Fagron's 1Q23 update shows solid performance, with
robust topline growth in key regions," KBC Securities says
** The broker adds the high note of the update is North
American compounding showing sustained strong growth and nearing
the 50 mln euros per quarter mark
** "We expect a positive share price reaction and mid-single
digit upgrades to FY2023 EBITDA consensus," said ING in a note
** The stock is on track for a best day since Feb. 9
($1 = 0.9106 euros)
(Reporting by Dina Kartit)
((dina.kartit@thomsonreuters.com))